Tenofovir Alafenamide for Pregnant Chinese Women with Active Chronic Hepatitis B: A Multicenter Prospective Study

Data on long-term tenofovir alafenamide (TAF) therapy for pregnant women with active chronic hepatitis B (CHB, immune clearance and reactivation phases [currently and previously diagnosed]) and their infants are lacking.

Source: Clinical Gastroenterology and Hepatology - December 10, 2021 Category: Gastroenterology Authors: Qing-Lei Zeng, Hong-Xu Zhang, Ji-Yuan Zhang, Shuo Huang, Wei-Zhe Li, Guang-Ming Li, Ya-Jie Pan, Ying-Hua Feng, Zhi-Qin Li, Guo-Fan Zhang, Jiang-Hai Xu, Wan-Bao Lin, Guang-Hua Xu, Na Liu, Guo-Qiang Zhang, Guo-Tao Li, Wei Li, Yan-Li Zeng, Ning Song, Meng Wa Source Type: research